Treatment Results with 5-mm Surgical Excision in Nonmelanoma Skin Cancers Analysis of 234 Cases
PDF

Original Article

Treatment Results with 5-mm Surgical Excision in Nonmelanoma Skin Cancers Analysis of 234 Cases

Turk J Dermatol 2023;17(2):69-72 DOI: 10.4103/tjd.tjd_120_22
, ,
PDF
Permissions

Abstract

Background:

Basal cell carcinoma and squamous cell carcinoma constitute the majority of nonmelanoma skin cancers. In our study, we analyzed our results of nonmelanoma skin cancer treatment with 5-mm surgical excision and compared them with the literature.

Material and Methods:

Patients treated at Ankara City Hospital Plastic, Reconstructive, and Aesthetic Surgery Clinic between February 2019 and March 2022 were included in this study. Demographic data, anatomical region, tumor subtype/differentiation, surgical margins, reconstruction method, and recurrence parameters were recorded. IBM SPSS Statistics (version 26.0) was used for the data analysis.

Results:

Of the 234 cases, 163 were reported as basal cell and 71 as squamous cell cancer. Margin positivity with 5-mm surgical excision was 14.1% and 16.9% in basal and squamous cell cancer, respectively. Nineth-month recurrence rates were 4.2% and 19.7% in basal and squamous cell cancer, respectively.

Conclusions:

All surgical margin positivity and recurrences were located in the head and neck regions, revealing the importance of developing treatment references according to the anatomical region.

Keywords: Basal cell cancer, local neoplasm recurrence, margins of excision, recurrence, skin neoplasms, squamous cell carcinoma